annb0t
Top 20
Immutep Limited
SYDNEY, AUSTRALIA, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutepâ or âthe Companyâ), a clinical-stage biotechnology company developing novel immunotherapies for cancer and autoimmune disease, today announced that Marc Voigt, CEO, and Deanne Miller, COO, will participate in two upcoming investor conferences.
Event:        Cantor Fitzgeraldâs Oncology, Hematology & HemeOnc Conference
D...
>>> Read more: Immutep to Participate in Two Upcoming Investor Conferences
SYDNEY, AUSTRALIA, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutepâ or âthe Companyâ), a clinical-stage biotechnology company developing novel immunotherapies for cancer and autoimmune disease, today announced that Marc Voigt, CEO, and Deanne Miller, COO, will participate in two upcoming investor conferences.
Event:        Cantor Fitzgeraldâs Oncology, Hematology & HemeOnc Conference
D...
>>> Read more: Immutep to Participate in Two Upcoming Investor Conferences
